Canada markets close in 5 hours 10 minutes

Hanall Biopharma Co., Ltd. (009420.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
33,950.00-250.00 (-0.73%)
At close: 03:30PM KST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
134,909,838
134,909,838
109,995,419
101,594,444
88,602,270
Cost of Revenue
59,737,569
59,737,569
48,024,129
41,261,831
37,951,232
Gross Profit
75,172,268
75,172,268
61,971,290
60,332,613
50,651,038
Operating Expenses
Research Development
23,944,952
23,944,952
16,498,472
10,462,423
9,316,282
Selling General and Administrative
25,688,359
25,688,359
23,235,914
20,523,423
17,379,245
Total Operating Expenses
72,960,909
72,960,909
60,465,503
50,233,494
44,715,850
Operating Income or Loss
2,211,359
2,211,359
1,505,787
10,099,119
5,935,188
Interest Expense
63,863
63,863
21,875
25,480
16,009
Income Before Tax
3,202,532
3,202,532
1,929,430
8,702,090
19,225,289
Income Tax Expense
-306,075
-306,075
1,677,956
-194,047
-539,210
Income from Continuing Operations
3,508,608
3,508,608
251,474
8,896,137
19,764,499
Net Income
3,508,608
3,508,608
251,474
8,896,137
19,764,499
Net Income available to common shareholders
3,508,608
3,508,608
251,474
8,896,137
19,764,499
Basic EPS
120.00
-
5.00
174.00
386.00
Diluted EPS
120.00
-
5.00
174.00
386.00
Basic Average Shares
49,674
-
50,295
51,127
51,203
Diluted Average Shares
49,674
-
50,295
51,127
51,203